Sean Murphy - 12 Feb 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CHIEF FINANCIAL OFFICER, Director
Signature
/s/ Sean Murphy
Issuer symbol
TLSI
Transactions as of
12 Feb 2024
Transactions value $
$0
Form type
4
Filing time
14 Feb 2024, 18:17:05 UTC
Previous filing
25 Jan 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +34,144 +2.05% $0 50,788 12 Feb 2024 Direct F1
holding TLSI Common Stock 357,535 12 Feb 2024 By Murphy Family Trust 2012 F2
holding TLSI Common Stock 167,732 12 Feb 2024 By Sean E Murphy TTEE U/A 2/4/2004

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +105,000 $0 105,000 12 Feb 2024 Common Stock 105,000 $9.5 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012.
F3 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.